Wealthcare Advisory Partners LLC Acquires 1,942 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Wealthcare Advisory Partners LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 59.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,186 shares of the healthcare conglomerate’s stock after purchasing an additional 1,942 shares during the period. Wealthcare Advisory Partners LLC’s holdings in UnitedHealth Group were worth $2,730,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Verdence Capital Advisors LLC raised its holdings in shares of UnitedHealth Group by 2.1% in the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after purchasing an additional 342 shares in the last quarter. Ascension Capital Advisors Inc. purchased a new stake in UnitedHealth Group during the 3rd quarter worth approximately $216,000. Bellecapital International Ltd. boosted its holdings in shares of UnitedHealth Group by 1.4% in the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock valued at $7,277,000 after acquiring an additional 193 shares during the last quarter. Great Valley Advisor Group Inc. boosted its holdings in shares of UnitedHealth Group by 5.8% in the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock valued at $17,292,000 after acquiring an additional 1,884 shares during the last quarter. Finally, Rise Advisors LLC boosted its holdings in shares of UnitedHealth Group by 326.0% in the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock valued at $112,000 after acquiring an additional 163 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 0.4 %

Shares of UNH traded up $1.93 during mid-day trading on Monday, reaching $494.38. The stock had a trading volume of 2,024,579 shares, compared to its average volume of 4,385,424. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The firm has a market cap of $454.87 billion, a price-to-earnings ratio of 30.22, a P/E/G ratio of 1.43 and a beta of 0.55. The business’s fifty day moving average is $481.70 and its 200 day moving average is $512.16. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period last year, the business earned $6.26 EPS. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on UNH shares. Deutsche Bank Aktiengesellschaft upped their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Oppenheimer reissued an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target on the stock in a report on Thursday, April 4th. Barclays upped their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Finally, Truist Financial restated a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.